(Q87857581)
Statements
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors (English)
Razelle Kurzrock
Johanna C Bendell
David S Hong
Howard A Burris
Aung Naing
Suzanne F Jones
Gerald Falchook
Patricia Bricmont
Agnes Elekes